Boston Scientific Corporation (BSX)

Boston Scientific Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	865	928	1,925	1,734	217
Cash & Cash Equivalents	865	928	1,925	1,734	217
Cash Growth	-6.79%	-51.79%	11.01%	699.08%	48.63%
Receivables	2,228	1,970	1,778	1,531	1,828
Inventory	2,484	1,867	1,610	1,351	1,579
Other Current Assets	937	995	1,004	2,078	1,075
Total Current Assets	6,514	5,760	6,317	6,694	4,699
Property, Plant & Equipment	2,859	2,446	2,252	2,084	2,079
Goodwill and Intangibles	20,390	18,822	18,109	15,868	18,062
Other Long-Term Assets	5,373	5,441	5,551	6,131	5,725
Total Long-Term Assets	28,622	26,709	25,912	24,083	25,866
Total Assets	35,136	32,469	32,229	30,777	30,565
Accounts Payable	942	862	794	513	542
Current Debt	531	20	261	13	1,416
Other Current Liabilities	3,460	2,921	3,219	3,155	2,908
Total Current Liabilities	4,933	3,803	4,274	3,681	4,866
Long-Term Debt	8,571	8,915	8,804	9,130	8,592
Other Long-Term Liabilities	2,102	2,178	2,529	2,640	3,230
Total Long-Term Liabilities	10,673	11,093	11,333	11,770	11,822
Total Liabilities	15,606	14,896	15,607	15,451	16,688
Total Debt	9,102	8,935	9,065	9,143	10,008
Debt Growth	1.87%	-1.43%	-0.85%	-8.64%	41.84%
Retained Earnings	819	-750	-1,392	-2,378	-2,253
Comprehensive Income	49	269	263	207	270
Shareholders' Equity	19,282	17,573	16,622	15,326	13,877
Net Cash / Debt	-8,237	-8,007	-7,140	-7,409	-9,791
Net Cash Per Share	-5.63	-5.56	-4.98	-5.23	-6.94
Working Capital	1,581	1,957	2,043	3,013	-167
Book Value Per Share	13.27	12.29	11.69	10.82	9.97

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).